Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis

References

• Stern G. A. Update on the medical management of corneal and external eye diseases, corneal transplantation, and keratorefractive surgery. Ophthalmology 1988; 95: 842–854
   PubMed Web of Science ®Google Scholar
• Wilson L. A. Acute bacterial infection of the eye: Bacterial keratitis and endophthalmitis. Trans. Ophthalmol. Soc. UK. 1986; 105: 43–60
   PubMedGoogle Scholar
• Hazlett L. D., Zucker M., Berk R. S. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res. 1992; 24: 32–39
   PubMed Web of Science ®Google Scholar
• Van Horn D. L., Davis S. D., Hyndiuk R. A., Pederson H. J. Experimental Pseudomonas keratitis in the rabbit: Bacteriologic, clinical, and microscopic observations. Invest. Ophthalmol. Vis. Sci. 1981; 20: 213–221
   PubMed Web of Science ®Google Scholar
• Thiel H. J., Steuhl K. P., Doring G. Therapy of. Pseudomonas aeruginosa. Antibiot. Chemother. 1987; 39: 92–101
   PubMedGoogle Scholar
• Steuhl K. P., Doring G., Henni A., Thiel H. J., Botzenhart K. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest. Ophthalmol. Vis. Sci. 1987; 28: 1559–1568
   PubMed Web of Science ®Google Scholar
• Trinkaus-Randall V., Leibowitz H. M., Ryan W. J., Kupferman A. Quantification of stromal destruction in the inflamed cornea. Invest. Ophthalmol. Vis. Sci. 1991; 32: 603–609
   PubMed Web of Science ®Google Scholar
• Bazan N. G., Bazan H. E. P. Ocular response to inflammation and the triggering of wound healing: Lipid mediators, proto-oncogenes, gene expression, and neuromodulation. New Trends Lipid Mediators Res. 1990; 5: 168–180
   Google Scholar
• Jones D. B. Pathogenesis of bacterial and fungal keratitis. Trans. Ophthalmol. Soc. U.K. 1978; 98: 367–371
   PubMedGoogle Scholar
• Hobden J. A., Engel L. S., Callegan M. C., Hill J. M., Gebhardt B. M., O'Callaghan R. J. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr. Eye. Res. 1993; 12: 461–467
   PubMed Web of Science ®Google Scholar
• Hobden J. A., O'Callaghan R. J., Hill J. M., Reidy J. J., Rootman D. S., Thompson H. W. Tobramycin iontophoresis into corneas infected with drug resistant. Pseudomonas aeruginosa. Curr. Eye Res. 1989; 8: 1163–1169
   PubMed Web of Science ®Google Scholar
• Badenoch P. R., Coster D. J. Antibiotics and corticosteroids: Functions and interaction in ocular disease. The Cornea: Transactions of the World Congress on the Cornea III, H. D. Cavanagh. Raven Press, New York 1988; 475–483
   Google Scholar
• Leibowitz H. M., Kupferman A. Use of corticosteroids in the treatment of corneal inflammation. Corneal Disorders, Clinical Diagnosis and Management, H. M. Leibowitz. W.B. Saunders, Philadelphia 1987; 286–310
   Google Scholar
• Leibowitz H. M., Kupferman A. Topically administered corticosteroids: Effect of antibiotic-treated bacterial keratitis. Arch. Ophthalmol. 1980; 99: 1587–1290
   Google Scholar
• Gritz D. C., Lee T. Y., Kwito S., McDonnell P. J. Topical antiinflammatory agents in an animal model of microbial keratitis. Arch. Ophthalmol. 1990; 108: 1001–1005
   PubMed Web of Science ®Google Scholar
• Hobden J. A., O'Callaghan R. J., Hill J. M., Hagenah M., Insler M. S., Reidy J. J. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis. Curr. Eye Res. 1992; 11: 259–266
   PubMed Web of Science ®Google Scholar
• Gritz D. C., Kwitko S., Trousdale M. D., Gonzales V. H., McDonnell P. J. Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model. Cornea 1992; 11: 404–408
   PubMedGoogle Scholar
• Stern G. A., Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalomology 1991; 98: 847–853
   PubMed Web of Science ®Google Scholar
• Hobden J. A., Engel L. S., Hill J. M., Callegan M. C., O'Callaghan R. J. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr. Eye Res. 1993; 12: 469–473
   PubMed Web of Science ®Google Scholar
• Carmichael T. R., Gelfand Y., Welsh N. H. Topical steroids in the treatment of central and paracentral corneal ulcers. Br. J. Ophthalmol. 1990; 74: 528–531
   PubMed Web of Science ®Google Scholar
• Rootman D. S., Hobden J. A., Jantzen J. A., Gonzalez V. R., O'Callaghan R. J., Hill J. M. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit. Arch. Ophthalmol. 1988; 106: 262–265
   PubMed Web of Science ®Google Scholar
• Hobden J. A., Rootman D. S., O'Callaghan R. J., Hill J. M. Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas. Antimicrob. Agents Chemother. 1988; 32: 978–981
   PubMed Web of Science ®Google Scholar
• Hobden J. A., Reidy J. J., O'Callaghan R. J., Hill J. M. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1940–1944
   PubMed Web of Science ®Google Scholar
• Hobden J. A., Reidy J. J., O'Callaghan R. J., Insler M. S., Hill J. M. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2241–2243
   PubMed Web of Science ®Google Scholar
• Reidy J. J., Hobden J. A., Hill J. M., Forman K., O'Callaghan R. J. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1991; 10: 25–28
   PubMed Web of Science ®Google Scholar
• Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: Selection of a control strain and criteria for magnesium and calcium content in the media. J. Infect. Dis. 1974; 130: 454–463
   PubMed Web of Science ®Google Scholar
• Engel L. S., Callegan M. C., Hill J. M., O'Callaghan R. J. Bioassay for quantitating ciprofloxacin and tobramycin in aqueous humor. J. Ocul. Pharmacol. 1994; 9: 311–320
   Google Scholar
• Johnson M. K., Hobden J. A., Hagenah M., O'Callaghan R. J., Hill J. M., Chen S. The role of pneumolysin in ocular infections with. Streptococcus pneumoniae. Curr. Eye Res. 1990; 9: 1107–1114
   PubMed Web of Science ®Google Scholar
• SAS for Linear Models: A Guide to the Anova and GLM Procedures. SAS Series in statistical Applications., R. J. Freund, R. C. Littel. SAS Institute, Cary, North Carolina 1981
   Google Scholar
• Leibowitz H. M., Kupferman A. Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Tram. Acad. Ophth. Otol. 1975; 79: 78–88
   Google Scholar
• Leibowitz H. M., Kupferman A. Antiinflammatory effectiveness in the cornea of topically administered prednisolone. Invest. Ophthalmol. 1974; 13: 757–763
   PubMedGoogle Scholar
• Kupferman A., Leibowitz H. M. Antiinflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium. Invest. Ophthalmol. 1975; 14: 252–255
   PubMedGoogle Scholar
• McGhee C. N. J. Pharmacokinetics of ophthalmic corticosteroids. Br. J. Ophthalmol. 1992; 76: 681–684
   PubMed Web of Science ®Google Scholar
• Haynes R. C., Murad F. Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 7th Ed, L. S. Goodman, A. G. Gilman. Macmillan, New York 1985; 1475–1477
   Google Scholar
• Cantin A., Woods D. E. Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J. Clin. Invest. 1993; 91: 38–45
   PubMed Web of Science ®Google Scholar
• Weiss S. J. Tissue destrucion by neutrophils. New England J. Med. 1989; 320: 365–376
   PubMed Web of Science ®Google Scholar